Father chops off 18-year-old son’s hand for watching porn on phone

New Delhi, Jun 3: India registered its highest single-day spike in COVID-19 cases on Wednesday with 8,909 more cases reported in the last 24 hours, taking the country's tally to 2,07,615, while the death toll rose to 5,815 according to the Union Health and Family Welfare Ministry.

The number of active COVID-19 cases stood to 1,01,497 while 1,00,303 people have been cured/discharged/migrated.

According to the Union Health and Family Welfare Ministry, out of all the states, Maharashtra has recorded the highest number of coronavirus cases with 72,300 patients followed by Tamil Nadu with 24,586 cases.

Kanpur, Jul 8: The Special Task Force (STF) shot dead Amar Dubey in an encounter in Maudaha on Wednesday morning. Amar, a right hand man of gangster Vikas Dubey, who shot dead eight police personnel on Friday last, figured prominently in the list of wanted persons released by the Kanpur police on Tuesday.

He was a named accused in the massacre.

According to STF sources, the police team had received a tip off about Amar's presence in the district and when they tried to close in on him, the criminal opened fire on them, He was killed in retaliatory firing around 6.30.a.m,

Amar was reportedly heading towards the house of one of his relatives in Maudaha area.

"We asked him to surrender but he opened fire at us and was killed when we returned the fire," said an STF official.

Earlier, he had been hiding in Faridabad but moved out after police pressure increased there.

Amar Dubey was a trusted accomplice of Vikas Dubey and the police had announced a reward of Rs 25,000 on him after the Kanpur massacre.

Incidentally, reports claim that Vikas Dubey was also seen at a hotel in Faridabad on Tuesday night but fled before the police could close in on him.

Tokyo, Mar 4: Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.

The Japanese drugmaker is working on a plasma-derived therapy to treat high-risk individuals infected with the new coronavirus and will share its plans with members of the U.S. Congress on Wednesday, it said in a statement.

Takeda is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.

"We will do all that we can to address the novel coronavirus threat...(and) are hopeful that we can expand the treatment options," Rajeev Venkayya, president of Takeda's vaccine business, said in the statement.

Takeda said it was in talks with various health and regulatory agencies and healthcare partners in the United States, Asia and Europe to move forward its research into the drug.

Its research requires access to the blood of people who have recovered from the respiratory disease or who have been vaccinated, once a vaccine is developed, Takeda said.